FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) Financial Services Profile

FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) offers a buffered exposure to the SPDR S&P 500 ETF Trust, targeting a capped upside of 11.73% and buffering against losses between -5% and -30% from October 2025 to October 2026. This fund caters to investors seeking defined risk management within the asset management sector.

What Is the Investment Thesis for DOCT?

DOCT presents a targeted investment strategy for investors seeking defined risk parameters. The fund's capped upside of 11.73% and buffered downside between -5% and -30% offer a specific risk-return profile relative to the SPDR S&P 500 ETF Trust from October 2025 to October 2026. A key value driver is the fund's ability to attract investors who prioritize downside protection and are willing to forgo some potential upside. Growth catalysts include increased investor awareness of defined outcome ETFs and a growing demand for risk management tools. The fund's success depends on its ability to accurately track the SPDR S&P 500 ETF Trust and maintain its defined buffer and cap levels. Potential risks include tracking error, changes in market volatility, and competition from similar products.

Based on FMP financials and quantitative analysis

DOCT Key Highlights

Market Cap of $388M indicates moderate investor interest and fund size.

• Beta of 0.49 suggests lower volatility compared to the broader market, aligning with the fund's buffered strategy.
• The fund's defined outcome period from October 20, 2025, to October 16, 2026, provides a clear timeframe for its investment strategy.
• The upside cap of 11.73% limits potential gains but offers a defined return target.
• The buffer against losses between -5% and -30% provides downside protection during the specified period.

Who Are DOCT's Competitors?

DOCT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are DOCT's Key Strengths?

Defined risk-return profile.

• Buffered downside protection.
• Capped upside potential.
• Specific time horizon.

What Are DOCT's Weaknesses?

Limited upside potential.

• Tracking error risk.
• Reliance on the performance of the SPDR S&P 500 ETF Trust.
• Complexity of the investment strategy.

What Could Drive DOCT Stock Higher?

Increased investor awareness of defined outcome ETFs.

• Growing demand for risk management tools.
• Expansion of the defined outcome ETF market.

What Are the Key Risks for DOCT?

Tracking error between the fund's performance and the SPDR S&P 500 ETF Trust.

• Changes in market volatility affecting the fund's performance.
• Competition from other defined outcome ETFs.
• Regulatory changes impacting the ETF industry.

What Are the Growth Opportunities for DOCT?

• Increased Adoption of Defined Outcome ETFs: The growing awareness and acceptance of defined outcome ETFs present a significant growth opportunity for DOCT. As investors seek strategies to navigate market volatility and manage risk, defined outcome ETFs are becoming increasingly attractive. The market for these products is expanding, driven by demand from both retail and institutional investors. DOCT can capitalize on this trend by educating investors about its specific risk-return profile and highlighting its benefits in a volatile market environment.
• Expansion of Product Line: FT Vest could expand its suite of defined outcome ETFs to offer different cap levels, buffer ranges, and underlying indexes. This would allow the company to cater to a wider range of investor preferences and risk tolerances. For example, the company could launch ETFs that track different market segments or offer different levels of downside protection. This diversification of product offerings would enhance the company's competitive position and attract new investors.
• Partnerships with Financial Advisors: Collaborating with financial advisors can significantly expand DOCT's reach and distribution. Financial advisors play a crucial role in educating clients about investment products and recommending suitable strategies. By partnering with financial advisory firms, DOCT can gain access to a broader investor base and increase its assets under management. These partnerships can involve training programs, marketing materials, and other initiatives to promote the benefits of DOCT to financial advisors and their clients.
• Enhanced Marketing and Education: Investing in marketing and educational initiatives can help DOCT raise awareness and attract new investors. This can include online advertising, social media campaigns, webinars, and educational content that explains the fund's strategy and benefits. By effectively communicating its value proposition, DOCT can differentiate itself from competitors and attract investors who are seeking defined outcome solutions. A strong marketing and education strategy is essential for driving growth and increasing market share.
• Institutional Adoption: While defined outcome ETFs have primarily been adopted by retail investors, there is a growing opportunity to attract institutional investors. These investors, such as pension funds and endowments, are increasingly seeking strategies to manage risk and generate consistent returns. DOCT can target institutional investors by highlighting its defined risk-return profile and its potential to enhance portfolio diversification. Successfully attracting institutional investors would significantly increase DOCT's assets under management and drive long-term growth.

What Are DOCT's Competitive Advantages?

• Defined Outcome Strategy: Offers a unique investment approach with a capped upside and buffered downside.
• Specific Time Horizon: Provides a defined investment period, catering to investors with specific goals.
• Brand Recognition: FT Vest is a recognized provider of defined outcome ETFs.

What Does DOCT Do?

The FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) is designed to provide investors with a unique investment strategy focused on defined outcome investing. The fund seeks to replicate the price return of the SPDR S&P 500 ETF Trust (SPY) up to a predetermined upside cap, while also providing a buffer against a specific range of losses. This strategy is implemented over a defined period, from October 20, 2025, to October 16, 2026. The fund's objective is to offer investors a balance between potential gains and downside protection. DOCT does not have a traditional founding story like operating companies. It was created as part of a suite of defined outcome ETFs. The ETF's evolution is tied to the growing demand for investment products that offer more predictable risk-return profiles. The fund operates within the asset management industry, providing a specific type of investment vehicle. The fund's geographic reach is primarily the U.S. market, as it tracks the SPDR S&P 500 ETF Trust. DOCT competes with other ETFs and investment products that offer similar defined outcome strategies or buffered exposure to the S&P 500. Its competitive positioning relies on the specific cap and buffer levels it offers, as well as its expense ratio and trading liquidity.

What Products and Services Does DOCT Offer?

• Provides investors with exposure to the SPDR S&P 500 ETF Trust (SPY).
• Offers a capped upside return, limiting potential gains to a predetermined level.
• Provides a buffer against a specific range of losses in the SPY.
• Operates over a defined period, from October 20, 2025, to October 16, 2026.
• Seeks to match the price return of the SPDR S&P 500 ETF Trust up to 11.73%.
• Buffers against Underlying ETF losses between -5% and -30%.

How Does DOCT Make Money?

• The fund generates revenue through management fees charged to investors.
• The management fee is a percentage of the fund's assets under management (AUM).
• The fund's profitability depends on its ability to attract and retain investors, as well as its expense management.

What Industry Does DOCT Operate In?

DOCT operates within the asset management industry, specifically in the growing segment of defined outcome ETFs. These ETFs aim to provide investors with a more predictable risk-return profile compared to traditional index funds. The market for defined outcome ETFs has been expanding as investors seek tools to manage volatility and achieve specific financial goals. The competitive landscape includes other ETF providers offering similar buffered or capped strategies, such as BJAN, BJUL, DECW, DJUN, and GAUG. The growth of this segment is driven by factors such as increased market volatility and a greater focus on risk management.

Who Are DOCT's Key Customers?

• Retail investors seeking defined risk-return profiles.
• Financial advisors looking for tools to manage client portfolios.
• Institutional investors seeking downside protection strategies.

FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) Valuation Context

Valued at $388M, DOCT is classified as a small-cap stock. Relative to its peer group, DOCT's quantitative score of 47/100 is roughly in line with the peer average of 47/100.

Return on equity for FT Vest U.S. Equity Deep Buffer ETF - October stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. DOCT trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

DOCT Financials

DOCT Latest News

No recent news available for DOCT.

DOCT Analyst Consensus

DOCT MoonshotScore

DOCT Financial Services Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources